CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer

Clinical trial NCT07704801 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07704801
Sponsor: Sohag University
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2021-01-01
Primary completion: 2026-11-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.